View in EDS

EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.

Saved in:
Bibliographic Details
Title: EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.
Authors: Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. eterpos@med.uoa.gr., Boccadoro M; Department of Biotechnology and Health Science, University of Torino, Turin, Italy., Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France., Mateos MV; University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands., Cook G; Leeds Institute of Clinical Trial Research, University of Leeds, Leeds, UK.; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Engelhardt M; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg, University of Freiburg, Faculty of Freiburg, Freiburg, Germany., Delforge M; Department of Hematology, University Hospital Leuven, Leuven, Belgium., Hajek R; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway., Gay F; University Division of Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Manier S; Department of Hematology, Lille University Hospital, Lille, France.; INSERM UMR-S1277 and CNRS UMR9020, Lille, France., Weisel KC; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kaiser M; Department of Haematology, The Royal Marsden Hospital, London, UK.; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Rodriguez-Otero P; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain., Perrot A; Université de Toulouse, Centre Hospitalo-Universitaire, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Driessen C; Department of Medical Oncology and Hematology, HOCH Health Ostchweiz, St. Gallen, Switzerland., Bila J; Clinic of Hematology, University Clinical Center of Serbia, Medical Faculty, University of Belgrade, Belgrade, Serbia., Laane E; Hematology-Oncology Clinic, Tartu University, Tartu, Estonia., Dytfeld D; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland., Touzeau C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France., Beksac M; Ankara Liv Hospital, Istinye University, Ankara, Turkey., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Faculty, Heidelberg, Germany., Cavo M; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Mohty M; Centre de Recherche Saint-Antoine INSERM UMRs938, Sorbonne Université, Paris, France.; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France., Spencer A; Department of Malignant Hematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Ludwig H; Wilhelminen Cancer Research Institute, First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria., Einsele H; Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany., San-Miguel J; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Sep; Vol. 22 (9), pp. 680-700. Date of Electronic Publication: 2025 Jul 07.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40624367
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dimopoulos+MA%22">Dimopoulos MA</searchLink>; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Terpos+E%22">Terpos E</searchLink>; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. eterpos@med.uoa.gr.<br /><searchLink fieldCode="AU" term="%22Boccadoro+M%22">Boccadoro M</searchLink>; Department of Biotechnology and Health Science, University of Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Zweegman+S%22">Zweegman S</searchLink>; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Leeds Institute of Clinical Trial Research, University of Leeds, Leeds, UK.; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Engelhardt+M%22">Engelhardt M</searchLink>; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg, University of Freiburg, Faculty of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Delforge+M%22">Delforge M</searchLink>; Department of Hematology, University Hospital Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Hajek+R%22">Hajek R</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Schjesvold+F%22">Schjesvold F</searchLink>; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gay+F%22">Gay F</searchLink>; University Division of Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Manier+S%22">Manier S</searchLink>; Department of Hematology, Lille University Hospital, Lille, France.; INSERM UMR-S1277 and CNRS UMR9020, Lille, France.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kaiser+M%22">Kaiser M</searchLink>; Department of Haematology, The Royal Marsden Hospital, London, UK.; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22van+de+Donk+NWCJ%22">van de Donk NWCJ</searchLink>; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Zamagni+E%22">Zamagni E</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Otero+P%22">Rodriguez-Otero P</searchLink>; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; Université de Toulouse, Centre Hospitalo-Universitaire, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Driessen+C%22">Driessen C</searchLink>; Department of Medical Oncology and Hematology, HOCH Health Ostchweiz, St. Gallen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bila+J%22">Bila J</searchLink>; Clinic of Hematology, University Clinical Center of Serbia, Medical Faculty, University of Belgrade, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Laane+E%22">Laane E</searchLink>; Hematology-Oncology Clinic, Tartu University, Tartu, Estonia.<br /><searchLink fieldCode="AU" term="%22Dytfeld+D%22">Dytfeld D</searchLink>; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland.<br /><searchLink fieldCode="AU" term="%22Touzeau+C%22">Touzeau C</searchLink>; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Beksac+M%22">Beksac M</searchLink>; Ankara Liv Hospital, Istinye University, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Faculty, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Cavo+M%22">Cavo M</searchLink>; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Mohty+M%22">Mohty M</searchLink>; Centre de Recherche Saint-Antoine INSERM UMRs938, Sorbonne Université, Paris, France.; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Spencer+A%22">Spencer A</searchLink>; Department of Malignant Hematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ludwig+H%22">Ludwig H</searchLink>; Wilhelminen Cancer Research Institute, First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany.<br /><searchLink fieldCode="AU" term="%22San-Miguel+J%22">San-Miguel J</searchLink>; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sonneveld+P%22">Sonneveld P</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101500077%22">Nature reviews. Clinical oncology</searchLink> [Nat Rev Clin Oncol] 2025 Sep; Vol. 22 (9), pp. 680-700. <i>Date of Electronic Publication: </i>2025 Jul 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101500077 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1759-4782 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217594774%22">17594774 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40624367
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41571-025-01041-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 680
    Titles:
      – TitleFull: EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dimopoulos MA
      – PersonEntity:
          Name:
            NameFull: Terpos E
      – PersonEntity:
          Name:
            NameFull: Boccadoro M
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Mateos MV
      – PersonEntity:
          Name:
            NameFull: Zweegman S
      – PersonEntity:
          Name:
            NameFull: Cook G
      – PersonEntity:
          Name:
            NameFull: Engelhardt M
      – PersonEntity:
          Name:
            NameFull: Delforge M
      – PersonEntity:
          Name:
            NameFull: Hajek R
      – PersonEntity:
          Name:
            NameFull: Schjesvold F
      – PersonEntity:
          Name:
            NameFull: Gay F
      – PersonEntity:
          Name:
            NameFull: Manier S
      – PersonEntity:
          Name:
            NameFull: Weisel KC
      – PersonEntity:
          Name:
            NameFull: Kaiser M
      – PersonEntity:
          Name:
            NameFull: van de Donk NWCJ
      – PersonEntity:
          Name:
            NameFull: Zamagni E
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Otero P
      – PersonEntity:
          Name:
            NameFull: Perrot A
      – PersonEntity:
          Name:
            NameFull: Driessen C
      – PersonEntity:
          Name:
            NameFull: Bila J
      – PersonEntity:
          Name:
            NameFull: Laane E
      – PersonEntity:
          Name:
            NameFull: Dytfeld D
      – PersonEntity:
          Name:
            NameFull: Touzeau C
      – PersonEntity:
          Name:
            NameFull: Beksac M
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Cavo M
      – PersonEntity:
          Name:
            NameFull: Mohty M
      – PersonEntity:
          Name:
            NameFull: Spencer A
      – PersonEntity:
          Name:
            NameFull: Ludwig H
      – PersonEntity:
          Name:
            NameFull: Einsele H
      – PersonEntity:
          Name:
            NameFull: San-Miguel J
      – PersonEntity:
          Name:
            NameFull: Sonneveld P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1759-4782
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Nature reviews. Clinical oncology
              Type: main
ResultId 1